Convalescent Plasma Treatment in Severe 2009 H1N1 Infection

Status Completed

Clinical Trial Summary

Treatment of severe 2009 H1N1 infection with convalescent plasma will reduce mortality.

Clinical Trial Description

Patients presented with severe 2009 H1N1 infection responded poorly to antiviral agents. Meta-analysis of reports from 1918 H1N1 pandemic suggested that convalescent plasma might be an effective treatment option for patients with severe 2009 H1N1 infection. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Influenza A

Clinical Trial Details

NCT number	NCT01306773
Study type	Interventional
Source	The University of Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03999554` - Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines	Phase 1
Completed	`NCT06385821` - A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus	Phase 3
Completed	`NCT02487173` - Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B	N/A
Completed	`NCT01701752` - Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults	Phase 1
Enrolling by invitation	`NCT03207152` - Biomarkers Predicting Infectivity in an Experimental Human Influenza Model	Phase 1
Terminated	`NCT05567783` - A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A	Phase 2
Not yet recruiting	`NCT00987012` - The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients	N/A
Not yet recruiting	`NCT05928507` - FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol
Completed	`NCT03651544` - The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac	Phase 1
Completed	`NCT02623322` - A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults	Phase 2
Completed	`NCT03196661` - Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population	Phase 1
Recruiting	`NCT06160531` - Influenza Viral Challenge Study of CC-42344 in Healthy Participants	Phase 2
Recruiting	`NCT06191393` - SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings	N/A
Completed	`NCT06127108` - Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel	N/A
Completed	`NCT05163730` - Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel	N/A
Not yet recruiting	`NCT06392451` - LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia	N/A
Recruiting	`NCT04896853` - Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®	Phase 1
Not yet recruiting	`NCT05787444` - Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)
Completed	`NCT05354115` - Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.	N/A
Completed	`NCT02014870` - Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers	Phase 1